General Information of This Metabolic Reaction (MR) (ID:
MR007423) |
Formula |
|
Reactant |
CP-122721 |
Product |
CP-677623 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A (CYP3A)
|
DME Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Metabolize The Produtc of This MR
|
|
References |
1 |
In vitro metabolism of CP-122,721 ((2S,3S)-2-phenyl-3-[(5-trifluoromethoxy-2-methoxy)benzylamino]piperidine), a non-peptide antagonist of the substance P receptor. Drug Metab Pharmacokinet. 2007 Oct;22(5):336-49.
|
2 |
Metabolism, pharmacokinetics, and excretion of the substance P receptor antagonist CP-122,721 in humans: structural characterization of the novel major circulating metabolite 5-trifluoromethoxy salicylic acid by high-performance liquid chromatography-tandem mass spectrometry and NMR spectroscopy
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.